biotech
biotech Articles
Celldex Therapeutics was another big mover coming out of the Annual Meeting for the American Society of Clinical Oncology (ASCO). Unfortunately, the move was to the downside.
Published:
Last Updated:
Athenex expects to price 6 million shares in the range of $11 to $13 apiece for an initial public offering is valued up to more than $89 million.
Published:
Last Updated:
Juno Therapeutics aw its shares slide after the company reported updated clinical trial results at the Annual Meeting for the American Society of Clinical Oncology (ASCO).
Published:
Last Updated:
Aileron Therapeutics has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
Published:
Last Updated:
The Annual Meeting for the American Society of Clinical Oncology (ASCO) is currently underway in Chicago, and the health care sector is on the move.
Published:
Last Updated:
24/7 Wall St. takes a look at the ASCO annual meeting each year and picks out the companies that could have the biggest boom or bust at the conference.
Published:
Last Updated:
Mersana Therapeutics has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
Published:
Last Updated:
Minerva Neurosciences has amended its co-development agreement with Janssen Pharma will repurchase all of its shares owned by Johnson & Johnson Innovation.
Published:
Last Updated:
Just ahead of the 2017 annual meeting of the American Society of Clinical Oncology, a new report shows that more than 240 immuno-oncology medicines and vaccines are currently in development.
Published:
Last Updated:
When companies see their shares rise almost 50%, investors probably just assume the news is from a buyout or a merger. In Tuesday's massive gain in shares of Protagonist Therapeutics, it was that the...
Published:
Last Updated:
Here are seven speculative biotech and biohealth stocks where analysts gave huge upside calls during the month of May 2017.
Published:
Last Updated:
Protagonist Therapeutics Inc. (NASDAQ: PTGX) saw its shares move up so much on May 30 that some investors probably just assumed this was a takeover or that the company had major news shaking the...
Published:
Last Updated:
ImmunoGen watched its stock make a handy gain after the firm announced that had amended its license agreements with Sanofi.
Published:
Last Updated:
Protagonist Therapeutics saw its shares make a solid gain early on Tuesday after the company announced a key worldwide licensing and collaboration agreement with Janssen Biotech.
Published:
Last Updated:
The 2017 annual meeting of the American Society of Clinical Oncology (ASCO) runs from June 2 to June 6. The following companies have signaled that they will be presenting data, or data will be...
Published:
Last Updated: